United Kingdom · Question · Written question
UIN 83989
Rare Diseases: Drugs
Introduced
21 October 2025
Last action
6 November 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
6 November 2025
Summary
To ask the Secretary of State for Health and Social Care, how many of the commercial arrangements made by NHS England with marketing authorisation holders between January 2020 and September 2025 involving indication-specific pricing were for indications f
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
21 October 2025
Written question
To ask the Secretary of State for Health and Social Care, how many of the commercial arrangements made by NHS England with marketing authorisation holders between January 2020 and September 2025 involving indication-specific pricing were for indications f
Source: Commons
6 November 2025
Answer
Between January 2020 and September 2025, NHS England entered into 75 commercial arrangements involving indication-specific pricing. Of these, eight of the commercial agreements have involved indication-specific pricing for rare non-oncology conditions, an...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-10-21/83989
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1843296
- uk · wq-1843296 · source updated 6 November 2025